Uptake and metabolism of iron and iron oxide nanoparticles in brain astrocytes

Biochemical Society Transactions

Volumn 41, Issue 6, 2013, Pages 1588-1592

  Hohnholt, Michaela C ^a   Dringen, Ralf ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

Astrocyte; Ferritin; Haem; Iron; Nanoparticle; Transport

Indexed keywords

FERRIC ION; FERRITIN; FERROPORTIN; FERROUS ION; HEME; HEMIN; IRON; IRON OXIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; NANOPARTICLE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; ZINC TRANSPORTER;

ASTROCYTE; ASTROCYTE CULTURE; CELL MEMBRANE; CELL METABOLISM; CELL TRACKING; CONFERENCE PAPER; DEGRADATION; DOWN REGULATION; DRUG TARGETING; ENDOCYTOSIS; INTERNALIZATION; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; PINOCYTOSIS; PRIORITY JOURNAL; REMYELINIZATION; SURFACE CHARGE; SYNTHESIS; UPREGULATION;

ANIMALS; ASTROCYTES; BRAIN; FERRIC COMPOUNDS; HUMANS; IRON; NANOPARTICLES;

EID: 84887959333     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130114     Document Type: Conference Paper

References (49)

1. Dringen, R., Bishop, G.M., Koeppe, M., Dang, T.N. and Robinson, S.R. (2007) The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem. Res. 32, 1884-1890
2. Scheiber, I.F. and Dringen, R. (2013) Astrocyte functions in the copper homeostasis of the brain. Neurochem. Int. 62, 556-565
3. Gaasch, J.A., Lockman, P.R., Geldenhuys, W.J., Allen, D.D. and Van der Schyf, C.J. (2007) Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem. Res. 32, 1196-1208
4. Bradbury, M.W.B. (1997) Transport of iron in the blood-braincerebrospinal fluid system. J. Neurochem. 69, 443-454
5. Moos, T., Nielsen, T.R., Skjorringe, T. and Morgan, E.H. (2007) Iron trafficking inside the brain. J. Neurochem. 103, 1730-1740
6. Leitner, D.F. and Connor, J.R. (2012) Functional roles of transferrin in the brain. Biochim. Biophys. Acta 1820, 393-402
7. Robinson, S.R., Dang, T.N., Dringen, R. and Bishop, G.M. (2009) Hemin toxicity: a preventable source of brain damage following hemorrhagic stroke. Redox Rep. 14, 228-235
8. Hohnholt, M.C., Geppert, M., Luther, E.M., Petters, C., Bulcke, F. and Dringen, R. (2013) Handling of iron oxide and silver nanoparticles by astrocytes. Neurochem. Res. 38, 227-239
9. Tulpule, K., Robinson, S.R., Bishop, G.M. and Dringen, R. (2010) Uptake of ferrous iron by cultured rat astrocytes. J. Neurosci. Res. 88, 563-571
10. Lane, D.J., Robinson, S.R., Czerwinska, H., Bishop, G.M. and Lawen, A. (2010) Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. Biochem. J. 432, 123-132
11. Bishop, G.M., Dang, T.N., Dringen, R. and Robinson, S.R. (2011) Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia. Neurotox. Res. 19, 443-451
12. Oshiro, S., Kawamura, K., Zhang, C., Sone, T., Morioka, M.S., Kobayashi, S. and Nakajima, K. (2008) Microglia and astroglia prevent oxidative stress-induced neuronal cell death: implications for aceruloplasminemia. Biochim. Biophys. Acta 1782, 109-117
13. Lawen, A. and Lane, D.J. (2013) Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action. Antioxid. Redox Signaling 18, 2473-2507
14. Bishop, G.M., Scheiber, I.F., Dringen, R. and Robinson, S.R. (2010) Synergistic accumulation of iron and zinc by cultured astrocytes. J. Neural Transm. 117, 809-817
15. Keenan, B.M., Robinson, S.R. and Bishop, G.M. (2010) Effects of carboxylic acids on the uptake of non-transferrin-bound iron by astrocytes. Neurochem. Int. 56, 843-849
16. Song, N., Jiang, H., Wang, J. and Xie, J.X. (2007) Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. J. Neurosci. Res. 85, 3118-3126
17. Pelizzoni, I., Zacchetti, D., Campanella, A., Grohovaz, F. and Codazzi, F. (2013) Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden. Biochim. Biophys. Acta 1832, 1326-1333
18. Yang, L., Fan, M., Du, F., Gong, Q., Bi, Z.G., Zhu, Z.J., Zhu, L.L. and Ke, Y. (2012) Hypoxic preconditioning increases iron transport rate in astrocytes. Biochim. Biophys. Acta 1822, 500-508
19. Rathore, K.I., Redensek, A. and David, S. (2012) Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-α and TGF-β1. Glia 60, 738-750
20. Du, F., Qian, C., Qian, Z.M., Wu, X.M., Xie, H., Yung, W.H. and Ke, Y. (2011) Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP-protein kinase A pathway. Glia 59, 936-945
21. Connor, J.R. and Benkovic, S.A. (1992) Iron regulation in the brain: histochemical, biochemical, and molecular considerations. Ann. Neurol. 32 (Suppl.), S51-S61
22. Moos, T. (1996) Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J. Comp. Neurol. 375, 675-692
23. Hoepken, H.H., Korten, T., Robinson, S.R. and Dringen, R. (2004) Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J. Neurochem. 88, 1194-1202
24. Qian, Z.M., To, Y., Tang, P.L. and Feng, Y.M. (1999) Transferrin receptors on the plasma membrane of cultured rat astrocytes. Exp. Brain Res. 129, 473-476
25. Ishiguro, M., Imai, Y. and Kohsaka, S. (1995) Expression and distribution of low density lipoprotein receptor-related protein mRNA in the rat central nervous system. Mol. Brain Res. 33, 37-46
26. Dang, T.N., Bishop, G.M., Dringen, R. and Robinson, S.R. (2010) The putative heme transporter HCP1 is expressed in cultured astrocytes and contributes to the uptake of hemin. Glia 58, 55-65
27. Lara, F.A., Kahn, S.A., da Fonseca, A.C., Bahia, C.P., Pinho, J.P., Graca-Souza, A.V., Houzel, J.C., de Oliveira, P.L., Moura-Neto, V. and Oliveira, M.F. (2009) On the fate of extracellular hemoglobin and heme in brain. J. Cereb. Blood Flow Metab. 29, 1109-1120
28. Dang, T.N., Bishop, G.M., Dringen, R. and Robinson, S.R. (2011) The metabolism and toxicity of hemin in astrocytes. Glia 59, 1540-1550
29. Laird, M.D., Wakade, C., Alleyne, Jr, C.H. and Dhandapani, K.M. (2008) Hemin-induced necroptosis involves glutathione depletion in mouse astrocytes. Free Radical Biol. Med. 45, 1103-1114
30. Li, Z., Chen-Roetling, J. and Regan, R.F. (2009) Increasing expression of H-or L-ferritin protects cortical astrocytes from hemin toxicity. Free Radical Res. 43, 613-621
31. Mahmoudi, M., Stoeve, P., Milani, A.S. and Arbab, A.S. (2011) Superparamagnetic Iron Oxide Nanoparticles: Synthesis, Surface Engineering, Cytotoxicity and Biomedical Applications, Nova Science Publishers, New York
32. Geppert, M., Hohnholt, M.C., Thiel, K., Nurnberger, S., Grunwald, I., Rezwan, K. and Dringen, R. (2011) Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 22, 145101
33. Lamkowsky, M.C., Geppert, M., Schmidt, M.M. and Dringen, R. (2012) Magnetic field-induced acceleration of the accumulation of magnetic iron oxide nanoparticles by cultured brain astrocytes. J. Biomed. Mater. Res., Part A 100A, 323-334
34. Sun, Z., Yathindranath, V., Worden, M., Thliveris, J.A., Chu, S., Parkinson, F.E., Hegmann, T. and Miller, D.W. (2013) Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous systemrelevant cell culture models. Int. J. Nanomed. 8, 961-970
35. Geppert, M., Petters, C., Thiel, K. and Dringen, R. (2013) The presence of serum alters the properties of iron oxide nanoparticles and lowers their accumulation by cultured brain astrocytes. J. Nanopart. Res. 15, 1349-1364
36. Hohnholt, M.C., Geppert, M., Nurnberger, S., von Byern, J., Grunwald, I. and Dringen, R. (2010) Advanced biomaterials accumulation of citrate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Adv. Eng. Mater. 12, B690-B694
37. Pickard, M.R., Jenkins, S.I., Koller, C.J., Furness, D.N. and Chari, D.M. (2011) Magnetic nanoparticle labeling of astrocytes derived for neural transplantation. Tissue Eng., Part C 17, 89-99
38. Pickard, M. and Chari, D. (2010) Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields. Nanomedicine 5, 217-232
39. Geppert, M., Hohnholt, M., Gaetjen, L., Grunwald, I., Baumer, M. and Dringen, R. (2009) Accumulation of iron oxide nanoparticles by cultured brain astrocytes. J. Biomed. Nanotechnol. 5, 285-293
40. Sheng, W.S., Hu, S., Nettles, A.R., Lokensgard, J.R., Vercellotti, G.M. and Rock, R.B. (2010) Hemin inhibits NO production by IL-1β-stimulated human astrocytes through induction of heme oxygenase-1 and reduction of p38 MAPK activation. J. Neuroinflammation 7, 51
41. Geppert, M., Hohnholt, M.C., Nurnberger, S. and Dringen, R. (2012) Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater. 8, 3832-3839
42. van Landeghem, F.K. H., Maier-Hauff, K., Jordan, A., Hoffmann, K.T., Gneveckow, U., Scholz, R., Thiesen, B., Bruck, W. and von Deimling, A. (2009) Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30, 52-57
43. Murillo, T.P., Sandquist, C., Jacobs, P.M., Nesbit, G., Manninger, S. and Neuwelt, E.A. (2005) Imaging brain tumors with ferumoxtran-10, a nanoparticles magnetic resonance contrast agent. Future Med. 2, 871-882
44. Hohnholt, M., Geppert, M. and Dringen, R. (2010) Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells. Neurochem. Res. 35, 1259-1268
45. Schulz, K., Kroner, A. and David, S. (2012) Iron efflux from astrocytes plays a role in remyelination. J. Neurosci. 32, 4841-4847
46. Jeong, S.Y. and David, S. (2003) Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278, 27144-27148
47. Urrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N.P., Arredondo, M., Gonzalez-Billault, C. and Nunez, M.T. (2013) Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J. Neurochem. 126, 541-549
48. Olivieri, S., Conti, A., Iannaccone, S., Cannistraci, C.V., Campanella, A., Barbariga, M., Codazzi, F., Pelizzoni, I., Magnani, G., Pesca, M. et al. (2011) Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention. J. Neurosci. 31, 18568-18577
49. Tapryal, N., Mukhopadhyay, C., Das, D., Fox, P.L. and Mukhopadhyay, C.K. (2009) Reactive oxygen species regulate ceruloplasmin by a novel mRNA decay mechanism involving its 3′-untranslated region. Implications in neurodegenerative diseases. J. Biol. Chem. 284, 1873-1883